<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>14(6)</volume><submitter>Chen Z</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Hepatocellular carcinoma (HCC) is one of the leading causes of tumor-related death. MicroRNAs (miRNAs) belong to a subfamily of functional non-coding RNAs (ncRNAs) and are essential regulators of tumorigenesis. They affect tumor-related therapeutic response, tumor metastasis, and clinical outcomes of several human malignant tumors. However, the prognostic value of miRNAs and their role in the tumor immune microenvironment (TIME) of HCC have not been clarified.&lt;h4>Materials and methods&lt;/h4&gt;Raw RNA-sequencing data (mRNA and miRNA) and clinicopathological characteristics of HCC samples were downloaded from the TCGA-GDC database. The Perl programming language, R software, Cytoscape software, and several online databases were used to clarify the clinical significance and biol</pubmed_abstract><journal>American journal of translational research</journal><pagination>3610-3637</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9274565</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>A six-miRNA signature as a novel biomarker for improving prediction of prognosis and patterns of immune infiltration in hepatocellular carcinoma.</pubmed_title><pmcid>PMC9274565</pmcid><pubmed_authors>Lin S</pubmed_authors><pubmed_authors>Chen Z</pubmed_authors><pubmed_authors>Ding C</pubmed_authors><pubmed_authors>Ren K</pubmed_authors><pubmed_authors>Zhang L</pubmed_authors><pubmed_authors>Wan D</pubmed_authors></additional><is_claimable>false</is_claimable><name>A six-miRNA signature as a novel biomarker for improving prediction of prognosis and patterns of immune infiltration in hepatocellular carcinoma.</name><description>&lt;h4>Background&lt;/h4>Hepatocellular carcinoma (HCC) is one of the leading causes of tumor-related death. MicroRNAs (miRNAs) belong to a subfamily of functional non-coding RNAs (ncRNAs) and are essential regulators of tumorigenesis. They affect tumor-related therapeutic response, tumor metastasis, and clinical outcomes of several human malignant tumors. However, the prognostic value of miRNAs and their role in the tumor immune microenvironment (TIME) of HCC have not been clarified.&lt;h4>Materials and methods&lt;/h4&gt;Raw RNA-sequencing data (mRNA and miRNA) and clinicopathological characteristics of HCC samples were downloaded from the TCGA-GDC database. The Perl programming language, R software, Cytoscape software, and several online databases were used to clarify the clinical significance and biol</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-05-31T22:25:21.933Z</modification><creation>2022-07-19T08:52:54.679Z</creation></dates><accession>S-EPMC9274565</accession><cross_references><pubmed>35836899</pubmed></cross_references></HashMap>